Perioperative use of csDMARDs for rheumatoid arthritis

1 Australia & New Zealand Musculoskeletal Clinical Trials Network (ANZMUSC). Perioperative use of DMARDs in people with inflammatory arthritis. An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis. 2022 [version 2.8]. Accessed March 2023. Available from [URL].Return